emodin has been researched along with plumbagin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fischer, TC; Gosch, C; Gselmann, M; Mirbeth, B; Stich, K; Thallmair, V | 1 |
| Annab, LA; Banerji, A; Gopinath, G; Srinivas, G; Srinivas, P | 1 |
| Krishnamoorthi, S; Murugantham, B; Muthusami, S; Periyasamy, L; Sundaraj, R | 1 |
4 other study(ies) available for emodin and plumbagin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
Topics: Agrochemicals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Drug Stability; Erwinia amylovora; Flowers; Germination; Hydrogen-Ion Concentration; Malus; Microbial Sensitivity Tests; Naphthoquinones; Plant Diseases; Quinones; Toxicity Tests | 2012 |
Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Cell Division; Emodin; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; In Situ Nick-End Labeling; Membrane Potentials; Mitochondria; Naphthoquinones; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; RNA, Antisense; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 2004 |
Screening of MMP-2 Inhibiting Phytoconstituents for the Development of Newer Pancreatic Cancer Treatment Modalities.
Topics: Cell Line, Tumor; Early Detection of Cancer; Emodin; Humans; Matrix Metalloproteinase 2; Molecular Docking Simulation; Pancreatic Neoplasms | 2023 |